Search This Blog

Friday, August 9, 2019

AnaptysBio EPS beats by $0.10

AnaptysBio (NASDAQ:ANAB): Q2 GAAP EPS of -$0.89 beats by $0.10.
Revenue of $5M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)